Clinical Trial: Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07116928) titled 'Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease' on July 23.

Brief Summary: This study aims to investigate the impact of adding Ganagliflozin tablets to the current background therapy on preventing the progression of kidney disease in subjects with type 2 diabetes and chronic kidney disease. The efficacy and safety will be evaluated by comparing the effects of Ganagliflozin tablets and placebo tablets added to the current background treatment over 120 weeks

Study Start Date: Sept. 10

Study Type: INTERVENTIONAL

Condition: T2DM (Type 2 Diabetes Mellitus) CKD -...